ERYTHROPOIETIN TREATMENT OF IDIOPATHIC MYELOFIBROSIS

被引：0
|
作者：
SPIRITI, MAA
LATAGLIATA, R
AVVISATI, G
BATTISTEL, V
MONTEFUSCO, E
SPADEA, A
PETTI, MC
机构：
[1] BOHERINGER MANNHEIM ITALIA,CLIN RES,MONZA,ITALY
[2] UNIV ROMA LA SAPIENZA,DEPT HUMAN BIOPATHOL,I-00185 ROME,ITALY
来源：
HAEMATOLOGICA | 1993年 / 78卷 / 06期
关键词：
IDIOPATHIC MYELOFIBROSIS; ERYTHROPOIETIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background. In order to determine whether recombinant human erythropoietin (rHuEPO) may play a role in treating anemia in idiopathic myelofibrosis (IMF), a pilot study using high doses of rHuEPO- was conducted on patients with IMF. Methods and results. From September, 1990 to December, 1992, 7 patients (6 males and 1 female, median age 68 years) affected by IMF entered the trial. RHuEPO was administered subcutaneously 5 days a week at a dosage of 160 U/kg daily for three months. Out of 7 patients, 4 obtained a response. These responders received additional maintenance treatment with rHuEPO until relapse. Response duration was 6, 7, 10+, and 16 months, respectively. Treatment was well-tolerated. Conclusions. Our data suggest that rHuEPO may play a role in the treatment of anemia in some IMF patients.
引用
收藏
页码：371 / 373
页数：3
相关论文
共 50 条
  • [31] IDIOPATHIC MYELOFIBROSIS - A REVIEW
    HASSELBALCH, H
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 (02) : 65 - 72
  • [32] Idiopathic myelofibrosis in children
    Sekhar, M
    Prentice, HG
    Popat, U
    Anderson, D
    Janmohammed, R
    Roberts, I
    Britt, RP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) : 394 - 397
  • [33] MANAGEMENT OF IDIOPATHIC MYELOFIBROSIS
    KELSEY, PR
    GEARY, CG
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 1987, 9 (01): : 1 - 12
  • [34] HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS
    OZSOYLU, S
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 40 (03) : 280 - 280
  • [35] A possible role for STI571 in the treatment of idiopathic myelofibrosis
    Hasselbalch, HC
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (01) : 63 - 64
  • [36] CUTANEOUS EXTRAMEDULLARY HEMATOPOIESIS IN A PATIENT WITH IDIOPATHIC MYELOFIBROSIS IN TREATMENT WITH RUXOLITINIB
    Sole Rodriguez, M.
    Ruiz Mercado, M.
    Montero Cuadrado, I
    Pulpillo, A.
    Perez Simon, J. A.
    [J]. HAEMATOLOGICA, 2017, 102 : 331 - 331
  • [37] Ineffectiveness of interferon-γ in the treatment of idiopathic myelofibrosis:: a pilot study
    Heis-Vahidi-Fard, N
    Forberg, E
    Eichinger, S
    Chott, A
    Lechner, K
    Gisslinger, H
    [J]. ANNALS OF HEMATOLOGY, 2001, 80 (02) : 79 - 82
  • [38] Ineffectiveness of interferon-γ in the treatment of idiopathic myelofibrosis: a pilot study
    N. Heis-Vahidi-Fard
    E. Forberg
    S. Eichinger
    A. Chott
    K. Lechner
    H. Gisslinger
    [J]. Annals of Hematology, 2001, 80 : 79 - 82
  • [39] Idiopathic myelofibrosis and direct Coombs' positive anemia: Remission of refractory anemia after treatment with rituximab and evidence that rituximab may revert unresponsiveness to erythropoietin.
    Hasselbalch, HC
    Pedersen, M
    [J]. BLOOD, 2003, 102 (11) : 341B - 341B
  • [40] Reversal of bone marrow fibrosis in idiopathic myelofibrosis after treatment with α-interferon
    Domingues, MA
    Hæpers, ATC
    Massaut, IHB
    Vassallo, J
    Lorand-Metze, I
    [J]. HAEMATOLOGICA, 1998, 83 (12) : 1124 - 1125
12345